Cellular senescence: at the nexus between ageing and diabetes

Allyson K. Palmer, Birgit Gustafson, James L. Kirkland, Ulf Smith

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.

Original languageEnglish (US)
Pages (from-to)1835-1841
Number of pages7
Issue number10
StatePublished - Oct 1 2019


  • Ageing
  • Cellular senescence
  • Dasatinib
  • Diabetes
  • Geroscience
  • Life course development
  • Quercetin
  • Review
  • Senolytics
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Cellular senescence: at the nexus between ageing and diabetes'. Together they form a unique fingerprint.

Cite this